Literature DB >> 34102306

Recent increased incidence of invasive serogroup W meningococcal disease: A retrospective observational study.

Nichlas Hovmand1, Lene Fogt Lundbo2, Gitte Kronborg3, Sidsel Skou Voss4, Håkon Sandholdt5, Steen Hoffmann6, Palle Valentiner-Branth7, Thomas Benfield8.   

Abstract

OBJECTIVES: Neisseria meningitidis serogroup W incidence has increased. Mortality associated with serogroup W has been higher than for other serogroups. Here we report epidemiological characteristics and risks of poor outcomes associated with invasive meningococcal disease in Denmark since 1980.
METHODS: All cases of invasive meningococcal disease reported from 1980-2018 were analyzed. Incidence rates by age, sex, manifestation, and serogroup were calculated. Poisson regression was used to analyze the rise in serogroup W, and multivariate logistic analysis was used to analyze risk factors for mortality.
RESULTS: A total of 5825 cases were analyzed. Risk of serogroup W infection increased after 2015 compared with all previous periods. Younger (<20 years) and older age (≥60 years) was associated with an increased risk of serogroup W infection compared with being aged 20-39. Crude case fatality was 12.0%, 11.9%, 9.2%, and 7.9% for serogroups W, Y, C, and B, respectively. After adjustment for age, sex, and manifestation, 30-day mortality was comparable for serogroups. Older age and manifestation with sepsis independently predicted risk of death.
CONCLUSIONS: Invasive meningococcal disease caused by serogroup W has increased, but serogroup per se was not associated with an increased risk of 30-day mortality.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Denmark; Mortality; Neisseria meningitidis; Serogroup W

Year:  2021        PMID: 34102306     DOI: 10.1016/j.ijid.2021.05.086

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  1 in total

1.  Risk of sequelae after invasive meningococcal disease.

Authors:  Sidsel Skou Voss; Jens Nielsen; Palle Valentiner-Branth
Journal:  BMC Infect Dis       Date:  2022-02-11       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.